期刊
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
卷 54, 期 36, 页码 10460-10464出版社
WILEY-V C H VERLAG GMBH
DOI: 10.1002/anie.201502644
关键词
Alzheimer's disease; amyloid; bioinorganic chemistry; copper; peptides
资金
- Future Fellowship [FT110100199]
- ARC Linkage Infrastructure, Equipment and Facilities grant [LE130100061]
- Senior Research Fellowship
- Foundation for Polish Science TEAM Program
- European Regional Development Fund [TEAM 2009-4/1]
- National Science Centre of Poland [2014/15/B/ST5/05229]
- Centre for Preclinical Research and Technology (CePT)
- European Regional Development Fund
- Innovative Economy, The National Cohesion Strategy of Poland
- National Science Center of Poland SONATA project [2012/07/D/ST4/02187]
- Australian Research Council [LE130100061] Funding Source: Australian Research Council
Accumulation of the -amyloid (A) peptide in extracellular senile plaques rich in copper and zinc is a defining pathological feature of Alzheimers disease (AD). The A1-x (x=16/28/40/42) peptides have been the primary focus of Cu-II binding studies for more than 15years; however, the N-truncated A4-42 peptide is a major A isoform detected in both healthy and diseased brains, and it contains a novel N-terminal FRH sequence. Proteins with His at the third position are known to bind Cu-II avidly, with conditional logK values at pH7.4 in the range of 11.0-14.6, which is much higher than that determined for A1-x peptides. By using A4-16 as a model, it was demonstrated that its FRH sequence stoichiometrically binds Cu-II with a conditional K-d value of 3x10(-14)M at pH7.4, and that both A4-16 and A4-42 possess negligible redox activity. Combined with the predominance of A4-42 in the brain, our results suggest a physiological role for this isoform in metal homeostasis within the central nervous system.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据